Curcuma longa (http://ir.dut.ac.za/bitstream/handle/10321/52/Maharaj_2005.pdf?sequence=5) = Farbstoff gewonnen aus Blütenstand/asiatisch Gewürz/= Indian saffron.

http://ir.dut.ac.za/handle/10321/663 Öffentlich am 1 – 9 - 13

Embargoed

Zusammenfassung:

Introduction The purpose of this study was to determine the therapeutic potential of Curcuma longa 30CH when administered to healthy individuals, thus revealing the materia medica of the substance. It was also the aim of

this study to compare the existing therapeutic indications of the substance to the proving symptomatology. Methodology The proving took the form of a double-blind placebo controlled study and was conducted by 2 Master’s

in Technology: Homoeopathy students using 30 healthy subjects. Twenty four provers were given the active medication and six provers were given the placebo. The remedy was manufactured according to the German Homoeopathic Pharmacopoeia in 30CH potency. The proving ran for a period of six weeks. Results The symptoms extracted from the proving were placed in different sections according to the repertory and was compared to

the Ayurvedic and Phytotherapeutic indications of Curcuma longa. There were 202 symptoms produced as a result of the remedy, 141 rubrics were formulated using these symptoms. The largest number of rubrics i ii was

allocated to the mind, head and dreams section of the repertory, other smaller sections of prominence included the eye, ear, nose and throat sections. A wealth of information was gained once the comparison was made between Curcuma longa 30CH and the Phytotherapeutic and Ayurvedic indications of use. Similarities between the materia medica of Curcuma longa and the Phytotherapeutic indications of use were found to exist with respect to

sections such as eye, nose, face, stomach, stool, respiration, back, extremities, skin and generals. Conclusion The administration of Curcuma longa 30C to healthy provers according to the methodological protocol of this

study resulted in the production of a variety of defined proving symptoms which comprise the materia medica thereof (first objective of the study). The subsequent comparison of the proving symptoms with the existing

indications of Turmeric as an Ayurvedic and Phytotherapeutic medicine (second objective of the study) revealed clear correlations in a variety of defined areas.

http://ir.dut.ac.za/handle/10321/665 Öffentlich am 1 – 9 – 13

Zusammenfassung:

The aim of this study was to determine the effect that Curcuma longa 30CH would have on healthy individuals, and record the particular signs and symptoms produced. These signs and symptoms determine the therapeutic indications of this remedy, so that it may be prescribed according to the homoeopathic Law of Similars. The second aim of this study was to analyse the symptomatology of Curcuma longa 30CH in relation to a Doctrine of Signatures analysis of the Curcuma longa plant, in order to facilitate a more comprehensive understanding of the materia medica of this substance. Design The homoeopathic proving of Curcuma longa in 30CH potency took

the form of a double blind, randomized, placebo controlled trial. Thirty healthy provers were selected on the basis of them meeting with the necessary inclusion criteria (Appendix A). The provers were randomly divided into

2 groups, of which 20% (6 of the 30 provers) formed the placebo group and received non-medicated powders, and the remaining 80% (24 of the 30 provers) received medicated powders (verum). The 2 groups were not aware

of the nature of the substance that they were proving or the potency used. The provers recorded their mental, physical and emotional states over a period of a week prior to taking the remedy in order to establish a baseline for comparison after the administration of the remedy. Both verum and placebo were dispensed in the form of 6 powders. Each powder was taken sublingually 3 times daily for 2 days or until the prover experienced the onset of

any symptoms. Each prover kept a journal and recorded their proving signs and symptoms daily after administration of the remedy or the placebo. The data was collected and extracted from these journals and then assessed

by the researcher for suitability to be included in the materia medica of Curcuma longa. All data gathered from the case histories (Appendix C), physical examinations and group discussions were also considered for inclusion. Results A variety of mental, emotional and physical symptoms were produced and included in the materia medica of Curcuma longa. There were a total number of 202 symptoms that were produced as a result of the remedy,

which resulted in the formulation of 141 rubrics. The main mental and emotional symptoms that surfaced during the proving were depression, a deep sadness, changeability of moods, courage/confidence, relaxed/ calm and

less anger, agility, increased concentration, and vivid dreams. The physical symptoms noted were diarrhea, change in energy levels (too much or too little energy), burning sensations, headaches, heart palpitations and

increased breathing rates. The symptoms that came about during the proving clearly showed correlation and association with the nature and description of the Turmeric plant, this is in keeping with findings of previous

provings (Pistorius, 2006; Webster, 2002; Speckmeier, 2008 & Pather, 2009), furthermore as suggested by Richardson-Boedler (1999:173) the Doctrine of Signatures analysis of the Turmeric plant facilitated in the

interpretation of the proving symptoms and thus the materia medica of the remedy.

Rajkoomar, Suhana

URI: http://hdl.handle.net/10321/663

Datum: 2011

Zusammenfassung:

Introduction The purpose of this study was to determine the therapeutic potential of Curcuma longa 30CH when administered to healthy individuals, thus revealing the materia medica of the substance. It was also the aim of

this study to compare the existing therapeutic indications of the substance to the proving symptomatology. Methodology The proving took the form of a double-blind placebo controlled study and was conducted by 2 Master’s

in Technology: Homoeopathy students using 30 healthy subjects. Twenty four provers were given the active medication and six provers were given the placebo. The remedy was manufactured according to the German Homoeopathic Pharmacopoeia in 30CH potency. The proving ran for a period of six weeks. Results The symptoms extracted from the proving were placed in different sections according to the repertory and was compared

to the Ayurvedic and Phytotherapeutic indications of Curcuma longa. There were 202 symptoms produced as a result of the remedy, 141 rubrics were formulated using these symptoms. The largest number of rubrics i ii was allocated to the mind, head and dreams section of the repertory, other smaller sections of prominence included the eye, ear, nose and throat sections. A wealth of information was gained once the comparison was made between Curcuma longa 30CH and the Phytotherapeutic and Ayurvedic indications of use. Similarities between the materia medica of Curcuma longa and the Phytotherapeutic indications of use were found to exist with respect to

sections such as eye, nose, face, stomach, stool, respiration, back, extremities, skin and generals. Conclusion The administration of Curcuma longa 30C to healthy provers according to the methodological protocol of this study resulted in the production of a variety of defined proving symptoms which comprise the materia medica thereof (first objective of the study). The subsequent comparison of the proving symptoms with the existing indications

of Turmeric as an Ayurvedic and Phytotherapeutic medicine (second objective of the study) revealed clear correlations in a variety of defined areas.

Beschreibung:

Mini-dissertation submitted in partial compliance with the requirements for the Master’s Degree in Technology: Homoeopathy, Durban University of Technology, 2011.

Embargoed Until: 2013-09-01

Alternative Medicine Review Volume 14, Number 2 2009

Abstract

Curcuma longa (turmeric) has a long history of use in Ayurvedic medicine as a treatment for inflammatory conditions. Turmeric constituents include the three curcuminoids: curcumin (diferuloylmethane; the primary

constituent and the one responsible for its vibrant yellow color), demethoxycurcumin, and bisdemethoxycurcumin, as well as volatile oils (tumerone, atlantone, and zingiberone), sugars, proteins, and resins.

While numerous pharmacological activities, including antioxidant and antimicrobial properties, have been attributed to curcumin, this article focuses on curcumin’s anti-inflammatory properties and its use for inflammatory conditions. Curcumin’s effect on cancer (from an anti-inflammatory perspective) will also be discussed; however, an exhaustive review of its many anticancer mechanisms is outside the scope of this article. Research has

shown curcumin to be a highly pleiotropic molecule capable of interacting with numerous molecular targets involved in inflammation. Based on early cell culture and animal research, clinical trials indicate curcumin may

have potential as a therapeutic agent in diseases such as inflammatory bowel disease, pancreatitis, arthritis, and chronic anterior uveitis, as well as certain types of cancer. Because of curcumin’s rapid plasma clearance and

conjugation, its therapeutic usefulness has been somewhat limited, leading researchers to investigate the benefits of complexing curcumin with other substances to increase systemic bioavailability. Numerous in-progress

clinical trials should provide an even deeper understanding of the mechanisms and therapeutic potential of curcumin.

.

Vergleich: Siehe: Commelinidae. + Farbstoff.

Phytologie: Fördert Kreislauf

Vorwort/Suchen. Zeichen/Abkürzungen. Impressum.